The First AI Formulated Drug Reaches the Clinic: Inside Quotient Sciences' Phase I Milestone and Pharma's 2026 Inflection - June 16, 2026

Send us Fan Mail The First AI Formulated Drug Reaches the Clinic: Inside Quotient Sciences' Phase I Milestone and Pharma's 2026 Inflection Quotient Sciences, working with Intrepid Labs' machine learning, has begun what is reported as the first human clinical study of an AI designed drug formulation, after MHRA approval in the UK. Chris and Laura unpack the crucial difference between an AI designed molecule and an AI designed formulation, and what it means that there are now 200+ AI originate...